IRD vs PFE · rev $11.0M vs P/E 20, rev $62.58B
Opus Genetics, Inc. (IRD) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
IRD currently screens at market cap $35.7M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the IRD and PFE stock pages for the full models.
Not investment advice.